Genworth Financial Inc (GNW) concluded trading on Wednesday at a closing price of $7.38, with 6.01 million shares of worth about $44.33 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.74% during that period and on April 03, 2025 the price saw a gain of about 1.79%. Currently the company’s common shares owned by public are about 421.42M shares, out of which, 406.78M shares are available for trading.
Stock saw a price change of 3.22% in past 5 days and over the past one month there was a price change of 11.14%. Year-to-date (YTD), GNW shares are showing a performance of 5.58% which increased to 16.40% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.67 but also hit the highest price of $7.90 during that period. The average intraday trading volume for Genworth Financial Inc shares is 4.66 million. The stock is currently trading 7.11% above its 20-day simple moving average (SMA20), while that difference is up 5.56% for SMA50 and it goes to 7.51% higher than SMA200.
Genworth Financial Inc (NYSE: GNW) currently have 421.42M outstanding shares and institutions hold larger chunk of about 88.99% of that.
The stock has a current market capitalization of $3.07B and its 3Y-monthly beta is at 0.99. PE ratio of stock for trailing 12 months is 10.95, while it has posted earnings per share of $0.67 in the same period. It has a debt-to-equity ratio of 0.18. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GNW, volatility over the week remained 3.18% while standing at 2.82% over the month.
Stock’s fiscal year EPS is expected to rise by 33.06% while it is estimated to decrease by -33.33% in next year.
Coverage by Compass Point stated Genworth Financial Inc (GNW) stock as a Buy in their note to investors on May 05, 2016, suggesting a price target of $5.25 for the stock. On February 08, 2016, Compass Point Reiterated their recommendations, while on November 17, 2015, Goldman Initiated their ratings for the stock with a price target of $5. Stock get a Sell rating from UBS on November 04, 2015.
